ADIPOQ and type 2 diabetes mellitus: Indeed, adiponectin levels were found to be greater in patients with AI and mHC than in controls [106] and the GR genetic variant A3669G was found to be associated with a reduced the risk of developing type 2 diabetes in patients with Cushing’s syndrome [65].